Abstract
Purpose: Chronic gender-affirming hormone therapy (GAHT) with sublingual estradiol (SLE) has not been studied. We aimed to compare GAHT with SLE only, to combined oral (CO) estradiol and cyproterone acetate, in treatment-naive trans women.
Methods: Twenty-two trans women enrolled into either the CO arm or the SLE-only arm (0.5 mg four times daily) in this 6-month prospective study. Anthropometric and laboratory variables were collected at baseline and 3 and 6 months. At the study beginning and end, body composition was measured by dual-energy X-ray absorptiometry and bioelectrical impedance, and gender dysphoria, sexual desire, and function were assessed by validated questionnaires.
Results: Subjects in the SLE were older, 26.3±5.8 years versus 20.1±2.3 years, p=0.006. All anthropometric, body composition, and laboratory variables were identical at baseline. Although dysphoria appeared greater, and sexual function lower at baseline in the CO group, this canceled out after age adjustment. Both treatments induced similar biochemical and hormonal changes. Creatinine, hemoglobin and cholesterol decreased significantly, while testosterone was suppressed to the same level in both groups: 3.22 [1.47-5.0] nmol/L in the SLE group and 2.41 [0.55-8.5] nmol/L in the CO, p=0.65. Significant changes in body composition toward a more feminine body were noted in both groups. Dysphoria did not significantly improve in either group, while sexual desire and function decreased at six months in both, p<0.001.
Conclusions: Both treatments achieved similar clinical changes. At this stage, SLE, which repeatedly induces alarming excursions of serum estradiol throughout the day, appears to offer no advantage over the CO approach.
Thank you for explaining.
Personally we do not think desire decreases completely, but in our own experience it has changed and made us wish for different functioning. Perhaps we always had that to some degree but the problem is that medical science is not really a place for many of us to feel congruent in our desires and functioning, that is why it is a problem for many trans femmes, we believe.
As for functioning without the medical science currently able to provide us what we require, this can be true somewhat. However, it can be mitigated by alternative practices.
Estrogen increased desire significantly for me, but I personally wish it had decreased desire and functioning. I like the atrophy (esp. when I started to think of myself in normative terms as a woman), and I would prefer a much lower libido, I think I would (selfishly) be happy with no libido.
Part of the problem with this study is that it has such a small sample size, dysphoria clearly decreases for many trans people when they take HRT and there are many, much larger and better studies showing this.
I don’t really follow what you mean about medical science and congruence with desire and function, or what you mean by alternative practices.
We mean that medical science cannot give us certain body parts that would increase sexual functioning such a clitoris, certain glands nor ovaries, a womb etc (yet) and by alternative practises we mean kink or possibly certain cultural practises like tantra etc.